INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹36 Cr | ₹34 Cr | ₹33 Cr | ₹32 Cr | ₹66 Cr |
What is the latest Long Term Provisions ratio of INDOCO REMEDIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹36 Cr |
| Mar2024 | ₹34 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹32 Cr |
| Mar2021 | ₹66 Cr |
How is Long Term Provisions of INDOCO REMEDIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹36 Cr | 6.35 | |
| Mar2024 | ₹34 Cr | 0.86 | |
| Mar2023 | ₹33 Cr | 5.20 | |
| Mar2022 | ₹32 Cr | -52.15 | |
| Mar2021 | ₹66 Cr | - | |
Compare Long Term Provisions of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,843.7 Cr | -7.2% | -7% | -21.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -7.2% |
-7% |
-21.8% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses